{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:32:42Z","timestamp":1792006362562,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.diabres.2017.11.016","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T19:30:44Z","timestamp":1511292644000},"page":"178-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment"],"prefix":"10.1016","volume":"135","author":[{"given":"Ichiro","family":"Horie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Abiru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Hongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Natsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuko","family":"Sagara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Ando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2017.11.016_b0005","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.2337\/diabetes.54.12.3427","article-title":"Glucose transporters in human renal proximal tubular cells isolated from the urine of patients with non-insulin-dependent diabetes","volume":"54","author":"Rahmoune","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabres.2017.11.016_b0010","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","article-title":"SGLT2 inhibition \u2013 a novel strategy for diabetes treatment","volume":"9","author":"Chao","year":"2010","journal-title":"Nat Rev Drug Discovery"},{"key":"10.1016\/j.diabres.2017.11.016_b0015","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy balance after sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.11.016_b0020","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1002\/oby.21653","article-title":"How strongly does appetite counter weight loss? Quantification of the feedback control of human energy intake","volume":"24","author":"Polidori","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.diabres.2017.11.016_b0025","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1038\/oby.2012.59","article-title":"Weight loss induced by chronic dapagliflozin treatment is attenuated by compensatory hyperphagia in diet-induced obese (DIO) rats","volume":"20","author":"Devenny","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.diabres.2017.11.016_b0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1017\/S1368980011000504","article-title":"Comparison of relative validity of food group intakes estimated by comprehensive and brief-type self-administered diet history questionnaires against 16 d dietary records in Japanese adults","volume":"14","author":"Kobayashi","year":"2011","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.diabres.2017.11.016_b0035","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2188\/jea.JE20110075","article-title":"Both comprehensive and brief self-administered diet history questionnaires satisfactorily rank nutrient intakes in Japanese adults","volume":"22","author":"Kobayashi","year":"2012","journal-title":"J Epidemiol"},{"key":"10.1016\/j.diabres.2017.11.016_b0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2188\/jea.8.203","article-title":"Self-administered diet history questionnaire developed for health education: a relative validation of the test-version by comparison with 3-day diet record in women","volume":"8","author":"Sasaki","year":"1998","journal-title":"J Epidemiol"},{"key":"10.1016\/j.diabres.2017.11.016_b0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1253\/jcj.62.431","article-title":"Validity of a self-administered diet history questionnaire for assessment of sodium and potassium: comparison with single 24-hour urinary excretion","volume":"62","author":"Sasaki","year":"1998","journal-title":"Jpn Circ J"},{"key":"10.1016\/j.diabres.2017.11.016_b0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3177\/jnsv.46.285","article-title":"Serum biomarker-based validation of a self-administered diet history questionnaire for Japanese subjects","volume":"46","author":"Sasaki","year":"2000","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.diabres.2017.11.016_b0055","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/sj.ejcn.1602858","article-title":"Validation of self-reported energy intake by a self-administered diet history questionnaire using the doubly labeled water method in 140 Japanese adults","volume":"62","author":"Okubo","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.diabres.2017.11.016_b0060","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/thx.2009.115931","article-title":"Maternal fat consumption during pregnancy and risk of wheeze and eczema in Japanese infants aged 16\u201324 months: the Osaka Maternal and Child Health Study","volume":"64","author":"Miyake","year":"2009","journal-title":"Thorax"},{"key":"10.1016\/j.diabres.2017.11.016_b0065","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s00774-009-0095-1","article-title":"The impact of lifestyle factors on serum 25-hydroxyvitamin D levels: a cross-sectional study in Japanese women aged 19\u201325 years","volume":"27","author":"Ohta","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.diabres.2017.11.016_b0070","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/ajcn\/86.1.206","article-title":"Hardness (difficulty of chewing) of the habitual diet in relation to body mass index and waist circumference in free-living Japanese women aged 18\u201322 y","volume":"86","author":"Murakami","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2017.11.016_b0075","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/ajcn\/83.5.1185","article-title":"Dietary patterns associated with bone mineral density in premenopausal Japanese farmwomen","volume":"83","author":"Okubo","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2017.11.016_b0080","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/hr.2015.35","article-title":"Relationship between salt intake as estimated by a brief self-administered diet-history questionnaire (BDHQ) and 24-h urinary salt excretion in hypertensive patients","volume":"38","author":"Sakata","year":"2015","journal-title":"Hypertens Res"},{"key":"10.1016\/j.diabres.2017.11.016_b0085","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00125-014-3196-x","article-title":"Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes","volume":"57","author":"Polidori","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2017.11.016_b0090","doi-asserted-by":"crossref","first-page":"e0151511","DOI":"10.1371\/journal.pone.0151511","article-title":"Ipragliflozin improves hepatic steatosis in obese mice and liver dysfunction in type 2 diabetic patients irrespective of body weight reduction","volume":"11","author":"Komiya","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.diabres.2017.11.016_b0095","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/dom.12237","article-title":"Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice","volume":"16","author":"Tatarkiewicz","year":"2014","journal-title":"Diabetes Obes Metab"},{"issue":"843\u201362","key":"10.1016\/j.diabres.2017.11.016_b0100","first-page":"e9","article-title":"Efficacy and safety of the SGLT2 inhibitor luseogliflozin in Japanese patients with type 2 diabetes mellitus stratified according to baseline body mass index: pooled analysis of data from 52-week phase III trials","volume":"38","author":"Sakai","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.diabres.2017.11.016_b0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/jdi.12471","article-title":"Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: a subgroup analysis of five randomized clinical trials","volume":"7","author":"Kashiwagi","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.diabres.2017.11.016_b0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.diabet.2015.10.003","article-title":"Effect of canagliflozin on liver function tests in patients with type 2 diabetes","volume":"42","author":"Leiter","year":"2016","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2017.11.016_b0115","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"New Engl J Med"},{"key":"10.1016\/j.diabres.2017.11.016_b0120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S2213-8587(16)00052-8","article-title":"Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Wu","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabres.2017.11.016_b0125","doi-asserted-by":"crossref","first-page":"844","DOI":"10.14740\/jocmr2760w","article-title":"Increased hematocrit during sodium-glucose cotransporter 2 inhibitor therapy indicates recovery of tubulointerstitial function in diabetic kidneys","volume":"8","author":"Sano","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.diabres.2017.11.016_b0130","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.2337\/dc13-2338","article-title":"Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week open-label proof-of-concept trial","volume":"37","author":"Perkins","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2017.11.016_b0135","doi-asserted-by":"crossref","unstructured":"DeFronzo RA. Combination therapy with GLP-1 receptor agonist and SGLT2 inhibitor. DiabetesObesity Metab 2017.","DOI":"10.1111\/dom.12982"},{"key":"10.1016\/j.diabres.2017.11.016_b0140","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.diabres.2017.11.016_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.diabres.2017.11.016_b0150","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1152\/physrev.00055.2009","article-title":"Biology of human sodium glucose transporters","volume":"91","author":"Wright","year":"2011","journal-title":"Physiol Rev"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717308823?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822717308823?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:07:36Z","timestamp":1759172856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822717308823"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"alternative-id":["S0168822717308823"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2017.11.016","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased sugar intake as a form of compensatory hyperphagia in patients with type 2 diabetes under dapagliflozin treatment","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2017.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}